Alnylam Pharmaceuticals
ALNY
#572
Rank
C$56.66 B
Marketcap
C$427.23
Share price
-1.18%
Change (1 day)
17.73%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company